SARS-CoV-2
Ag Ultra
Lab-comparable results in just 5 minutes.
Verify potential infection quickly with a rapid microfluidic assay that provides actionable and lab-comparable results for patients suspected of COVID-19 in just 5 minutes.
Test benefits
- Microfluidic immunofluorescence assay
- Results in 5 minutes
- Optimize clinical workflow
- Sample type: nasal swab
- Easy to implement at point of care
- No refrigeration storage required: room temperature storage (2-30°C)
- Small and portable Instrument
- Minimal handling steps
Test workflow
The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning correctly for every test run.
The workflow process is comprised of a simple sample prep along with step-by-step guidance of the Instrument to report a patient result in under 5 minutes from sample application.
Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets. Available in the USA under Emergency Use Authorization for SARS-COV-2 assays.
Parempaa terveyttäParemmat kokemuksetParemmat hoitotulokset
Terveemmän elämän tukena yksilöille, yhteisöille ja koko yhteiskunnalle.
Mahdollistaa herkästi reagoivan, yksilöllisen hoitosuhteen potilaiden ja hoitotiimien välillä.
Kustannusten säätely ja vähentäminen terveydenhuollon budjettipaineiden helpottamiseksi.